ask="30.50"
ask_size="800"
average_daily_volume="1160670"
bid="30.01"
bid_size="100"
book_value="4.18"
change="-0.49"
change_from_200_day_moving_average="7.94"
change_from_50_day_moving_average="3.94"
change_from_52_week_high="-3.01"
change_From_52_week_low="14.59"
change_in_percent="-1.59%"
close="30.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.05"
ebitda="-278.87M"
eps_estimate_current_year="-4.92"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-3.77"
ex_dividend_date="N/A"
float_shares="44052000"
high="30.96"
high_52_weeks="33.28"
last_trade_date="2/16/2017"
last_trade_price="30.27"
last_trade_size="91579"
last_trade_time="4:00pm"
low="29.64"
low_52_weeks="15.68"
market_capitalization="1.71B"
moving_average_200_day="22.33"
moving_average_50_day="26.33"
name="Portola Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="29.75"
open="30.85"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+35.58%"
percent_change_from_50_day_moving_average="+14.98%"
percent_change_from_52_week_high="-9.04%"
percent_change_from_52_week_low="+93.05%"
previous_close="30.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.35"
price_per_sales="66.32"
revenue="26.23M"
shares_outstanding="56543000"
short_ratio="5.21"
stock_exchange="NMS"
symbol="PTLA"
volume="1429903"
weeks_range_52="15.68 - 33.28"
